cephalosporin

cephalosporin. Cephalosporins are a class of beta-lactam antibiotics that are similar to penicillin and are used to treat a wide range of bacterial infections, including those caused by Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli. They were first discovered by Giuseppe Brotzu at the University of Cagliari in Sardinia, and later developed by Oxford University and Merck & Co.. Cephalosporins are often used as an alternative to penicillin in patients who are allergic to penicillin, and are commonly prescribed by doctors and pharmacists at hospitals such as Massachusetts General Hospital and Johns Hopkins Hospital.

Introduction

Cephalosporins are a broad class of antibiotics that are used to treat a variety of infections, including pneumonia, skin infections, and urinary tract infections. They are commonly used in medicine and are available in a range of formulations, including oral and parenteral forms. Cephalosporins are often used in combination with other antibiotics, such as aminoglycosides and macrolides, to treat complex infections. Researchers at Harvard University and Stanford University have studied the use of cephalosporins in combination with other antibiotics to treat sepsis and other life-threatening infections. Cephalosporins are also used in veterinary medicine to treat infections in animals, including dogs and cats, at veterinary hospitals such as Cornell University College of Veterinary Medicine.

History

The discovery of cephalosporins is attributed to Giuseppe Brotzu, an Italian scientist who isolated the first cephalosporin, cephalosporin C, from a fungus in Sardinia in 1945. The development of cephalosporins as antibiotics was later pursued by Oxford University and Merck & Co., which led to the introduction of the first commercial cephalosporin, cephalothin, in the 1960s. Since then, numerous other cephalosporins have been developed, including ceftriaxone, ceftazidime, and cefepime, which are used to treat a range of infections, including those caused by Gram-negative bacteria such as Pseudomonas aeruginosa and Klebsiella pneumoniae. Scientists at National Institutes of Health and Centers for Disease Control and Prevention have studied the use of cephalosporins to treat antibiotic-resistant infections.

Mechanism_of_action

Cephalosporins work by inhibiting the synthesis of the bacterial cell wall, which is essential for the survival of bacteria. They bind to penicillin-binding proteins (PBPs) on the surface of bacterial cells, which prevents the cross-linking of peptidoglycan chains and ultimately leads to the lysis of the bacterial cell. This mechanism of action is similar to that of penicillin and other beta-lactam antibiotics, and is effective against a wide range of Gram-positive and Gram-negative bacteria, including Staphylococcus aureus and Escherichia coli. Researchers at University of California, Berkeley and University of Chicago have studied the mechanism of action of cephalosporins and their interaction with bacterial enzymes such as beta-lactamase.

Classification

Cephalosporins are classified into several generations based on their spectrum of activity and their resistance to beta-lactamase enzymes. First-generation cephalosporins, such as cefazolin and cephalexin, are effective against Gram-positive bacteria but have limited activity against Gram-negative bacteria. Second-generation cephalosporins, such as cefuroxime and cefaclor, have a broader spectrum of activity and are effective against some Gram-negative bacteria, including Haemophilus influenzae and Moraxella catarrhalis. Third-generation cephalosporins, such as ceftriaxone and ceftazidime, have an even broader spectrum of activity and are effective against a wide range of Gram-negative bacteria, including Pseudomonas aeruginosa and Klebsiella pneumoniae. Fourth-generation cephalosporins, such as cefepime and ceftobiprole, have a broad spectrum of activity and are resistant to many beta-lactamase enzymes. Pharmacists at American Society of Health-System Pharmacists and Infectious Diseases Society of America have developed guidelines for the use of cephalosporins in different clinical settings.

Side_effects

Cephalosporins are generally well-tolerated, but can cause a range of side effects, including gastrointestinal upset, allergic reactions, and renal impairment. Allergic reactions to cephalosporins can range from mild rash and itching to severe anaphylaxis, and can occur in patients who are allergic to penicillin. Renal impairment can occur in patients with pre-existing kidney disease, and can be exacerbated by the use of other nephrotoxic agents. Gastrointestinal upset can be minimized by taking cephalosporins with food, and probiotics such as Lactobacillus acidophilus and Bifidobacterium bifidum can help to maintain a healthy gut flora. Doctors at Mayo Clinic and Cleveland Clinic have developed guidelines for the management of side effects associated with cephalosporins.

Uses

Cephalosporins are used to treat a wide range of infections, including pneumonia, skin infections, and urinary tract infections. They are commonly used in hospitals and clinics to treat sepsis and other life-threatening infections, and are often used in combination with other antibiotics to treat complex infections. Cephalosporins are also used in veterinary medicine to treat infections in animals, including dogs and cats. Veterinarians at American Animal Hospital Association and American Veterinary Medical Association have developed guidelines for the use of cephalosporins in veterinary medicine. Cephalosporins have also been used to treat infections in livestock, including cattle and pigs, at farms and ranches such as Iowa State University and University of California, Davis. Category:Antibiotics